Evidence map›Paper›PMID 39251470›Full record

ArticleAnnals of nuclear medicine2025

Prognostic value of transient ischemic dilatation by

Yanni Jia, Yingqi Hu, Lihong Yang, Xin Diao, Yuanyuan Li, Yanhui Wang, Ruonan Wang, Jianbo Cao, Sijin Li

Abstract read
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Transient ischemic dilation withJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2026
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanni Jia *Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yingqi Hu *Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Lihong YangDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Xin DiaoDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yuanyuan LiDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yanhui WangDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Ruonan WangDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Jianbo CaoDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Sijin LiDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. lisjnm123@163.com.ORCID http://orcid.org/0000-0002-2010-3459

Funding

National Natural Science Foundation of China Grant Nos. U22A6008the First Hospital of Shanxi Medical University Hospital Fund Project Project No. SYYYRC-2023004the Shanxi Province Basic Research Program, the Youth Scientific Research Project Project No. 202303021222344
6 · The paper itself

Abstract

objectiveTransient ischaemic dilatation (TID) had incremental diagnostic and prognostic value in obstructive coronary artery disease (CAD), but its clinical significance in patients with non-obstructive CAD remains unknown. We aimed to explore the prognostic value of TID in patients with non-obstructive CAD by

methodsWe retrospectively studied 131 consecutive patients with non-obstructive CAD undergoing one-day rest-stress

resultsDuring a median follow-up of 42.08 ± 17.67 months, 22 (16.7%) patients occurred MACE. The optimal cut-off value of TID was 1.03 based on MACE. Our preliminary outcome analysis suggests that TID-abnormal subjects had a lower overall survival probability. Furthermore, our multivariate analysis reveals abnormal TID was the only independent predictor for MACE in non-obstructive CAD. In the subgroup analysis, an abnormal TID was an independent predictor for MACE in patients with abnormal perfusion patterns.

conclusionAmong patients with non-obstructive CAD, PET-derived TID ≥ 1.03 may identify those with a high risk of subsequent MACE independently. It was also an independent risk factor for poor prognosis in patients with abnormal perfusion.

Indexed as

AmmoniaCoronary Artery DiseaseMyocardial Perfusion ImagingNitrogen RadioisotopesPositron-Emission TomographyAgedFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesAmmoniaNitrogen-13Nitrogen Radioisotopes13N-ammonia PETMyocardial perfusion imagingNon-obstructive coronary artery diseasePrognosisTransient ischaemic dilatation

Identifiers

PMID39251470
PMCPMC11706881

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.